Salt water, saltier than body fluid, administered intranasally: it thins mucus and washes out what has settled. Pooled trials support symptom relief in hay fever and long-standing sinus inflammation, less reliance on allergy medicines, and faster clearing of crusts after sinus surgery. Certainty is low. Burning is common, nosebleeds occur, and untreated tap water has caused fatal brain infection. (Full Review)

Protocol

Standard regimen

2–3% buffered, 2–4 sprays per nostril

Sodium chloride, once or twice daily. Split dosing is standard. Older adults often need 1.5–2% rather than 3%.

Large-volume irrigation approach

150–240 mL per side daily

Squeeze-bottle delivery for sinus indications. Nasal polyps, prior sinus surgery and cystic fibrosis shift practice toward it.

Best time of day

Morning; evening 30–60 min before bed

Morning clears overnight secretions; evening use reduces nocturnal blockage. Within 30 minutes of lying down risks backward drainage.

Time to effect

Symptom improvement

4 weeks – 2 months

Pooled symptom gains, with consistent daily use. No measurable change by 8 weeks is the point to reconsider.

Sinonasal quality of life

3–6 months

In chronic rhinosinusitis, gains grow with duration of use but rest on low-quality evidence.

Congestion relief

Minutes

Often felt within minutes of a single use; contact time is roughly 10–20 minutes.

Benefits

High: Relief of allergic rhinitis symptoms; relief of chronic rhinosinusitis symptoms and sinonasal quality of life; faster mucosal recovery after sinus surgery

Medium: Reduced reliance on symptom medication

Low: Accelerated nasal mucociliary clearance; shorter and less transmissible common cold (conflicted)

Speculative: Broad-spectrum antiviral activity via chloride-dependent hypochlorous acid; reduced nasal deposition of airborne allergens and pollutants

Contraindications

Cerebrospinal fluid leak or unhealed skull-base defect (incl. within 12 weeks of pituitary or other skull-base surgery), unless the surgical team specifies rinses

Unrepaired septal perforation, or nasal fracture within the past 6 weeks

Active bleeding disorder or platelet count below 50 × 10⁹/L, or recurrent epistaxis requiring cautery in the past 3 months

Acute middle-ear infection, current eardrum perforation, or ear grommets (tympanostomy tubes) in place

Children under 2 years, and anyone with impaired airway protection or swallowing (reduced consciousness, weakness of the swallowing muscles)

Unable to source distilled, boiled-and-cooled, or 1-micron-filtered water

Key Interactions

Intranasal corticosteroids (fluticasone, mometasone, budesonide)

Intranasal antihistamines (azelastine, olopatadine)

Intranasal peptide and rescue medications (desmopressin, sumatriptan, naloxone, esketamine, insulin)

Topical decongestants (oxymetazoline, xylometazoline, phenylephrine)

Over-the-counter cromolyn sodium nasal spray

Supplement nasal sprays with additive osmotic or irritant load (xylitol rinses, povidone-iodine, N-acetylcysteine, colloidal silver)

Oral anticoagulants and antiplatelets (warfarin, apixaban, clopidogrel, high-dose fish oil)

Nasal continuous positive airway pressure and sinus surgery aftercare

Risk & Side Effects

High: Nasal burning, stinging and local discomfort

Medium: Epistaxis and mucosal bleeding

Low: Throat irritation and unpleasant taste; ear pain and pressure; fatal amoebic infection from contaminated water or device

Speculative: Ciliary impairment at excessive tonicity; preservative-related mucosal injury; disruption of protective mucus and nasal microbial ecology

Monitoring

Marker	Target	Why
SNOT-22 score	Below 9 points	Overall sinonasal symptom and quality-of-life burden
Total Nasal Symptom Score (TNSS)	0–2 of 12	Tracks blockage, runny nose, sneezing and itch specifically
Peak nasal inspiratory flow (PNIF)	Above 120 L/min in adults; within 10% of personal best	Objective measure of nasal airway opening, independent of symptom perception
Saccharin transit time	Under 15 minutes	Direct read-out of mucociliary clearance, the mechanism this intervention targets
Blood eosinophil count	0.05–0.20 × 10⁹/L	Identifies allergic inflammation that predicts larger symptom response
Total immunoglobulin E (IgE)	Under 50 IU/mL	Confirms an allergic pattern and gauges likely benefit from washout of allergens

Cadence: Baseline on two separate days before starting, then at 4 weeks, at 8 weeks, and every 3–6 months during continued use; post-surgical users are reassessed on the surgical team's endoscopy schedule instead.

Qualitative Assessment

Sleep quality, and whether the night is spent breathing through the nose rather than the mouth
Morning congestion on waking, and how long it takes to clear
Sense of smell and taste, which should not deteriorate
Energy levels and daytime alertness, as proxies for sleep fragmentation from obstruction
Cognitive clarity during high-pollen periods
Frequency of reaching for antihistamines or decongestants
Burning, stinging or bleeding after each session, as the tolerability signal that governs salinity

Hypertonic Saline Nasal Spray for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment